CPT1A and colorectal neoplasm: Comprehensive metabolomic analyses identified extensive acylcarnitine accumulation following CPT1A upregulation by Coriobacteriaceae, which then activated the MAPK signalling pathway, ultimately causing progression of colorectal tumours.